By Everdeen Mason
Danaher Corp. (DHR) expects its fourth-quarter adjusted earnings
and revenue to hit the high end of its previous forecast.
Danaher, which makes testing, diagnostic and medical equipment,
has posted improved revenue in recent years through acquisitions.
However, its bottom line has been under pressure from restructuring
charges, cost-cutting activities, and weakening economic and market
conditions.
The company projected earnings of 91 cents to 96 cents a share
in October, part of its trend of issuing conservative guidance. It
also estimated core revenue to grow 2% to 3%.
Chief Executive H. Lawrence Culp will discuss the results at the
J.P. Morgan Healthcare Conference on Wednesday.
Danaher shares rose 1.8% to $77.49 in recent trading, with the
stock up 30% in the past 12 months.
Write to Everdeen Mason at everdeen.mason@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires